Deal: Medtech startup Bionter secures $3 million seed financing

New York-based Dynamk Capital, a growth equity and venture capital firm focused on life sciences industrials, has led Bionter’s seed round to grow the team and accelerate the market launch of its fully automated particle counter based on a new combination of light obscuration technology and smart automation to enable non-destructive sample testing.

Wenger Vieli advised Dynamk Capital as lead investor in all legal matters. Our team was led by Marc Walter (Partner, M&A / Venture Capital) and included Cedric Fischer (Associate, M&A / Venture Capital), Dominik Rietiker (Associate, M&A / Venture Capital), and Dorian Loosli (Legal Advisor, M&A / Venture Capital).